Clearside Biomedical Inc Stock Ownership - Who owns Clearside Biomedical?

Insider buying vs selling

Have Clearside Biomedical Inc insiders been buying or selling?
Clay ThorpDirector2023-09-2510,000$0.86
William D. HumphriesDirector2023-09-2222,727$0.40
Charles A. DeignanChief Financial Officer2023-09-1334,090$0.40
Thomas CiullaChief Medical Officer2023-01-2013,700$1.47
Charles A. DeignanChief Financial Officer2023-01-1914,030$1.50
George M. LasezkayCEO2023-01-1920,030$1.46
Thomas CiullaChief Medical Officer2023-01-102,170$1.62
Thomas CiullaChief Medical Officer2022-12-315,000$0.95
Clay ThorpDirector2022-12-2114,000$1.02
Charles A. DeignanChief Financial Officer2022-12-2023,636$0.40

1 of 2

CLSD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CLSD insiders and whales buy or sell their stock.

CLSD Shareholders

What type of owners hold Clearside Biomedical Inc stock?
Clay Thorp11.32%7,019,083$5.90MInsider
Bradford T. Whitmore9.58%5,944,901$4.99MInsider
Hatteras Venture Advisors Iv Sbic LLC6.69%4,150,684$3.49MInsider
Hatteras Venture Advisors Iii LLC5.71%3,540,739$2.97MInsider
Carmignac Gestion3.87%2,400,344$2.02MInstitution
Vanguard Group Inc3.49%2,166,885$1.82MInstitution
Cormorant Asset Management LP3.21%1,988,208$1.67MInsider
Rmi Investments Sarl2.51%1,558,024$1.31MInsider
Blackrock Inc1.31%813,310$683.18kInstitution
Daniel H. White0.84%519,832$436.66kInsider

1 of 3

CLSD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CLSD13.68%42.22%Net BuyingNet Buying
DYAI8.03%91.97%Net Buying
IMMX3.91%50.21%Net BuyingNet Buying

Clearside Biomedical Stock Ownership FAQ

Who owns Clearside Biomedical?

Clearside Biomedical (NASDAQ: CLSD) is owned by 13.68% institutional shareholders, 42.22% Clearside Biomedical insiders, and 44.11% retail investors. Clay Thorp is the largest individual Clearside Biomedical shareholder, owning 7.02M shares representing 11.32% of the company. Clay Thorp's Clearside Biomedical shares are currently valued at $6.11M.

If you're new to stock investing, here's how to buy Clearside Biomedical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.